GCGprotein The search results for "gcg peptide" indicate a strong interest in the biological functions and therapeutic potential of peptides derived from the glucagon gene (GCG)作者：AM Puszkarska·2024·被引用次数：32—Helicalpeptidesthat are known to play key roles in maintaining metabolic homeostasis include, among others, glucagon (GCG) and glucagon-like .... The dominant search intent appears to be informational, focusing on understanding what GCG peptides are, their roles in glucose metabolism, and their connection to other related peptides like GLP-1.Glucagon-Like PeptideI; Glucagon-Like Peptide 1; Glucagon-Like Peptide1; GLP-I; GLPI; GLP-1; GLP1;GCG peptide. Description, GLP-1 (7-37) is a truncated ... There is also an underlying interest in therapeutic applications, particularly in the context of diabetes and weight management, and potentially in purchasing these peptides for research or other purposesExpression of the GCG gene and secretion of active glucagon ....
Tier 1 Entities and Phrases:
* GCG peptide
* Glucagon
* Peptide hormone
* Glucose metabolism
* GLP-1 (Glucagon-like peptide-1)
Tier 2 Entities and Phrases:
* Pancreatic hormone
* Alpha cells of the pancreas
* Insulin
* Glycogenolysis
* Gluconeogenesis
* GLP-2 (Glucagon-like peptide-2)
* Glicentin
* Oxyntomodulin
* GRPP (Glicentin-related polypeptide)
* Proglucagon
* GCG gene
* GCG receptor
* GCGR
* GLP-1R
* Dual receptor agonists
* Tri-agonist
* Weight loss
* Hypoglycemia
* Metabolic homeostasis
Tier 3 Entities and Phrases:
* Specific research paper titles or author names (unless directly illustrative of a key concept)
* Catalog numbers or specific product names (unless illustrative of availability)
* "GCG gene," "GCG protein," "GCG antagonist," "GCG inhibitors," "Gcg peptide for sale" (these are related but secondary to the core biological function and therapeutic interest)
---
The GCG peptide, most commonly known as glucagon, is a crucial peptide hormone produced primarily by the alpha cells of the pancreas. It plays a vital counterregulatory role to insulin, acting as a central regulator in glucose metabolism and maintaining metabolic homeostasis. Glucagon's primary function is to raise blood glucose levels by stimulating the liver to break down stored glycogen (glycogenolysis) and synthesize new glucose (gluconeogenesis). This intricate hormonal system ensures that the body has an adequate supply of glucose, especially between meals or during periods of fasting.
Beyond its direct role as glucagon, the GCG gene also serves as the precursor for a family of related bioactive peptides, including Glucagon-like peptide-1 (GLP-1), Glucagon-like peptide-2 (GLP-2), oxyntomodulin, and glicentin.作者：CX Deng·2026—Mazdutide: An emerging glucagon/GCG-likepeptide-1 dual receptor agonist for obesity—a comparison of therapeutic effects and potential side ... These proglucagon-derived peptides share a common origin and often exert significant influence on metabolic processes, making the GCG peptide family a focal point in endocrinology and metabolic research.
The peptides encoded by the GCG gene are not limited to regulating blood sugar.GCG| GLP2 | Glucagon | Glucagon-likepeptide2 | GRPP | Glicentin-related polypeptide | GLP1 | Glucagon-likepeptide1. Presentation. Lyophilized. Their functions extend to influencing appetite, insulin secretion, and nutrient absorption.
* Glucagon (GCG): As the primary GCG peptide, glucagon's main role is to prevent hypoglycemia (low blood sugar). It achieves this by signaling the liver to release stored glucose. In conditions like uncontrolled diabetes, elevated glucagon levels can contribute to hyperglycemia (high blood sugar).Glucagon-Like PeptideI; Glucagon-Like Peptide 1; Glucagon-Like Peptide1; GLP-I; GLPI; GLP-1; GLP1;GCG peptide. Description, GLP-1 (7-37) is a truncated ...
* Glucagon-like Peptide-1 (GLP-1): This is arguably the most extensively studied of the GCG-derived peptides due to its significant therapeutic implications. GLP-1 is an incretin hormone released from the gut in response to food intake. It enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety.Protagonist selects GLP-1/GIP/GCG receptor agonist ... These actions make GLP-1 receptor agonists a cornerstone in the treatment of type 2 diabetes and obesity.
* Glucagon-like Peptide-2 (GLP-2): While also derived from proglucagon, GLP-2 primarily acts on the gastrointestinal tract. It promotes intestinal growth and nutrient absorption, playing a role in maintaining gut health and function.
* Oxyntomodulin and Glicentin: These peptides also contribute to metabolic regulation, with oxyntomodulin showing potential effects on energy expenditure and appetite, while glicentin has a more complex role in the digestive system.
The distinct yet often interconnected functions of glucagon and GLP-1 have spurred significant research into developing therapeutic agents that can modulate their respective receptors (GCGR and GLP-1R).Human Glucagon-like Peptide 1 / GLP-1 (aa 7-36)
* Dual Receptor Agonists: A major area of innovation involves developing peptides that can activate both GLP-1 and glucagon receptors simultaneously.Human Synthetic Glucagon (GCG) Peptide | ABIN977326 These dual agonists aim to leverage the benefits of both hormones – the glucose-lowering and weight-reducing effects of GLP-1, combined with the potential for increased energy expenditure and appetite suppression from glucagon activation. Early research suggests these compounds can be highly effective for weight loss and improving glycemic control, offering a promising avenue for treating obesity and metabolic syndrome.
* Tri-agonists: Further advancements are exploring tri-agonists that target GLP-1, glucagon, and potentially other related receptors like GIP (glucose-dependent insulinotropic polypeptide).Glucagon-Like PeptideI; Glucagon-Like Peptide 1; Glucagon-Like Peptide1; GLP-I; GLPI; GLP-1; GLP1;GCG peptide. Description, GLP-1 (7-37) is a truncated ... These complex molecules represent a sophisticated approach to metabolic regulation, aiming for synergistic effects that surpass those of single- or dual-target therapies.
* Glucagon Antagonists: In contrast to agonists, glucagon antagonists are designed to block the action of glucagon.GCG/Glucagon General Information - Sino Biological These are being investigated for specific conditions where excessive glucagon activity is detrimental, such as in certain types of hypoglycemia or as a complement to insulin therapy in type 1 diabetes to prevent hyperglycemia.
The growing understanding of GCG peptides has led to their increased availability for research purposes.GCG glucagon GLP1 GLP2 GRPP | Sigma-Aldrich Various suppliers offer synthetic glucagon peptides and related compounds for laboratory studies. The development of novel GCG-based therapeutics, particularly GLP-1 and dual receptor agonists, is a dynamic field with numerous pharmaceutical companies actively pursuing clinical trials and aiming for market approval作者：DA Sandoval·2015·被引用次数：573—Gcgencodes multiplepeptidesincluding glucagon, glucagon-likepeptide-1, glucagon-likepeptide-2, oxyntomodulin, and glicentin. Of these .... These advancements highlight the profound impact that understanding the intricate signaling pathways involving GCG peptides has on both basic science and the development of cutting-edge medical treatments.
Join the newsletter to receive news, updates, new products and freebies in your inbox.